World Duchenne Organization
World Duchenne Organization is a Dutch nonprofit founded in 2005 that connects the global Duchenne and Becker muscular dystrophy community through awareness campaigns, an annual care conference, a patient advocate training academy, and EU-funded research partnerships, serving patients, families, clinicians, and advocates.
- Company typePrivate
- Founded2005
- HeadquartersVeenendaal, Netherlands
- Headcount11–50
- GTM typeB2C
- OfferingServices
What World Duchenne Organization does
World Duchenne Organization (WDO), legally Stichting World Duchenne Organization, is a Dutch nonprofit patient advocacy organization that has connected the global Duchenne and Becker muscular dystrophy (DMD/BMD) community since 2005. It serves families and caregivers of people with dystrophinopathies, clinicians and researchers, and patient advocates through a portfolio of programs: the annual World Duchenne Awareness Day, the annual Duchenne Care Conference (700+ registrants from 72 countries in the most recent edition, moving to a fully online model in 2026), and the Duchenne Patient Academy (500+ trained advocates from 55 countries since 2018, co-organized with the Duchenne Data Foundation). Additional programs include the Accredited Duchenne Centers Program, the DMD Emergency Program, the multilingual Duchenne Family Guide, and the FAIR Data for Duchenne initiative.
WDO's operating model is community-led and content-distribution driven rather than technology-platform driven. Its core "technology" is a comprehensive website hosting a scientific library, an online conference delivery layer (Zoom), and an online application system for academy admissions. It also acts as a patient-voice partner in several EU-funded research initiatives — BIND (brain involvement in dystrophinopathies, 300+ patients across seven EU centers), BEAMER, ERDERA, EURO-NMD Registry Hub, and Trials@Home — and is formally recognized by the European Medicines Agency, EURORDIS, the European Patients' Forum, Rare Diseases International, and EUPATI.
WDO is funded by individual donations, pharmaceutical and biotechnology event sponsorships (PTC Therapeutics, Sarepta, Roche, BioMarin, Italfarmaco, Santhera, Solid Biosciences, and Wave Life Sciences have sponsored the Duchenne Patient Academy), and EU research grants. All flagship community-facing services are free to participants; there is no consumer or enterprise pricing model. Revenue figures are not publicly disclosed. The organization is governed by a board and small staff (11–50 employees), headquartered in Amsterdam with operating presence across Europe and a growing transatlantic footprint via its partnership with Parent Project Muscular Dystrophy (PPMD).
World Duchenne Organization firmographics
Firmographics- Name
- World Duchenne Organization
- Legal name
- Stichting World Duchenne Organization
- Website
- https://worldduchenne.org
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- World Duchenne Organization is a Dutch nonprofit founded in 2005 that connects the global Duchenne and Becker muscular dystrophy community through awareness campaigns, an annual care conference, a patient advocate training academy, and EU-funded research partnerships, serving patients, families, clinicians, and advocates.
- Ownership category
- akta.pro rank
World Duchenne Organization industry classification
Industry- Product category
- Patient Advocacy and Rare Disease Support Services
- NAICS
- Other Individual and Family Services (624190), Scientific Research and Development Services (5417), Management, Scientific, and Technical Consulting Services (5416)
- SIC
- Services-Membership Organizations (8600), Services-Misc Health & Allied Services, Nec (8090), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)
- akta.pro secondary industries
- Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN), Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI)
Keywords
Where World Duchenne Organization is headquartered
LocationHeadquarters
- HQ city
- Veenendaal
- HQ country
- Netherlands
- HQ region
- Europe
Offices1 record
Markets served
World Duchenne Organization business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Donations and Grants: WDO operates as a nonprofit charitable foundation (Stichting World Duchenne Organization) that relies on donations from individuals, families, and organizations to fund its mission of improving treatment, quality of life, and long-term outlook for people affected by Duchenne and Becker muscular dystrophy. The organization accepts donations via PayPal and international bank transfers.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | One time | Free participation with registration required |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
World Duchenne Organization product offering
Product offeringCore offering
World Duchenne Organization is a Dutch nonprofit patient advocacy foundation that serves as a global hub for the Duchenne and Becker muscular dystrophy (DMD/BMD) community. It offers an annual international Duchenne Care Conference, the Duchenne Patient Academy online advocate training program, the annual World Duchenne Awareness Day campaign, and contributes to EU-funded research initiatives (BIND, BEAMER, ERDERA, EURO-NMD Registry Hub, Trials@Home). Its core product is a comprehensive information and community platform delivered through its website, supporting families, caregivers, clinicians, and patient organizations with condition information, care standards, and clinical trial guidance.
Product overview
The World Duchenne Organization operates primarily as a digital advocacy and information platform rather than a software product company. Its portfolio consists of patient-focused services and programs including the Duchenne Care Conference (annual international care meeting), Duchenne Patient Academy (patient advocate training), and the BIND Project (brain involvement research). The organization also runs awareness campaigns like World Duchenne Awareness Day, quality programs such as the Accredited Duchenne Centers Program, emergency assistance through the DMD Emergency Program, and educational resources including the Duchenne Family Guide. These programs are delivered through its website platform which serves as the central hub for information, news, research library, and community resources for the global Duchenne and Becker muscular dystrophy community.
Differentiator
Problem solved
Functional benefit
Products and services
- Duchenne Care Conference Annual international meeting bringing together clinicians, researchers, and patient organization representatives to share knowledge and advances in Duchenne and Becker MD care. Free to attend with registration required; previous edition attracted 700+ registrants from 72 countries.
- Duchenne Patient Academy Online training event for Duchenne and Becker patient advocates covering community building, drug development, patient advocacy, Standards of Care, and communication. Delivered in collaboration with Duchenne Data Foundation; has trained over 500 patient advocates from 55 countries since 2018.
- BIND Project (Brain Involvement in Dystrophinopathies) International research initiative dedicated to studying learning and behavioural challenges in DMD/BMD patients, with collected clinical data from more than 300 patients across seven EU centers. European Commission-funded.
- World Duchenne Awareness Day Annual global awareness initiative on Duchenne and Becker muscular dystrophy featuring documentary premieres, the Bad Shirt Friday campaign, and themed community engagement.
- Accredited Duchenne Centers Program Program that accredits healthcare centers meeting standards of care for Duchenne patients, providing a quality assurance framework for clinical care delivery.
- DMD Emergency Program Emergency assistance program activated during crises affecting the Duchenne and Becker community, providing rapid response support to patients and families.
- Duchenne Family Guide Comprehensive guide implementing updated standards of care for Duchenne patients, available in multiple languages, for use by families and caregivers.
Quantifiable outcome
- Over 500 patient advocates trained from 55 countries since 2018 through Duchenne Patient Academy
- +2 more outcomes
Companies that use World Duchenne Organization
Customer profileSegments3 records
Ideal customer profiles4 records
World Duchenne Organization technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
World Duchenne Organization partnerships and signals
Strategic signalPartnerships
22 partnerships are on record, tiered core and minor.
- Parent Project Muscular Dystrophy (PPMD)coreUS-based partner collaborating on World Duchenne Awareness Day 2025 initiatives, including the Bad Shirt Friday campaign and United Nations documentary premiere in New York.
- PTC TherapeuticsminorPharmaceutical company sponsor of Duchenne Patient Academy 2024, providing financial support for the training program for patient advocates.
- Sarepta TherapeuticsminorPharmaceutical company sponsor of Duchenne Patient Academy 2024, providing financial support for the training program for patient advocates.
- RocheminorPharmaceutical company sponsor of Duchenne Patient Academy 2024, providing financial support for the training program for patient advocates.
- BioMarinminorPharmaceutical company sponsor of Duchenne Patient Academy 2024, providing financial support for the training program for patient advocates.
- ItalfarmacominorPharmaceutical company sponsor of Duchenne Patient Academy 2024, providing financial support for the training program for patient advocates.
- SantheraminorPharmaceutical company sponsor of Duchenne Patient Academy 2024, providing financial support for the training program for patient advocates.
- Solid BioSciencesminorBiotechnology company sponsor of Duchenne Patient Academy 2024, providing financial support for the training program for patient advocates.
- Wave Life SciencesminorBiotechnology company sponsor of Duchenne Patient Academy 2024, providing financial support for the training program for patient advocates.
- Duchenne Data FoundationcoreCollaborative partner in organizing Duchenne Patient Academy. DDF and WDO work together to provide intensive training for patient advocates on key aspects needed to make a meaningful impact in the DMD/BMD field.
- BIND Project ConsortiumcoreInternational research consortium including seven EU centers focused on understanding brain involvement in dystrophinopathies. Consortium members include researchers from CNRS Paris-Saclay, Leiden University Medical Center, Kempenhaeghe, and other institutions.
- European Medicines Agency (EMA)coreRegulatory partner providing training opportunities and collaboration on medicines R&D, with WDO listed as a related organization on their website.
- European Patients Forum (EPF)coreStrategic partner for patient empowerment initiatives. WDO provides the EPF Toolkit on Patient Empowerment and participates in EPF Summer Training Course.
- EURORDIScoreAlliance partner in the rare diseases community. WDO offers EURORDIS Open Academy training to patient advocates and maintains organizational partnership.
- Rare Diseases InternationalcoreGlobal advocacy partner for rare diseases. WDO participates in #Resolution4Rare initiatives and maintains alliance membership.
- EUPATIcoreEducational partner providing the EUPATI Toolbox on Medicines R&D and EUPATI Patient Expert Training Course to patient advocates.
- Share4RareminorPlatform partner providing the Share4Rare Toolkit on Patient Advocacy as part of WDO's advocacy tools.
- European Neuromuscular Centre (ENMC)coreResearch partner hosting international workshops on Duchenne muscular dystrophy topics. WDO collaborates on workshops such as the bone protective therapy workshop.
- EU Project: BEAMERcoreEU-funded research project in which WDO participates as a partner organization.
- EU Project: ERDERAcoreEU-funded rare disease research partnership in which WDO participates as a partner organization.
- EU Project: EURO-NMD Registry HubcoreEU-funded registry project for neuromuscular diseases in which WDO participates as a partner organization.
- EU Project: Trials@HomecoreEU-funded project on decentralised clinical trials in which WDO participates as a partner organization.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
World Duchenne Organization competitors and assessment
Company assessmentDirect peers
- Duchenne UK: UK-focused DMD patient advocacy and research funder. Operates as a national-level peer with overlapping mission in cure acceleration, family support, and clinical trial infrastructure.
- EURORDIS - Rare Diseases Europe: European umbrella alliance for rare disease patient organizations. WDO is a member and strategic partner, making EURORDIS a direct peer in pan-European rare disease advocacy.
- Rare Diseases International: Global alliance of rare disease patient organizations. WDO participates in the #Resolution4Rare campaign, making it a peer in international rare disease policy advocacy.
- Parent Project Muscular Dystrophy (PPMD): Leading US-based DMD/BMD patient advocacy organization. WDO co-organized the 2025 World Duchenne Awareness Day with PPMD, indicating close peer-level collaboration on global advocacy campaigns.
- Duchenne Data Foundation: Collaborative partner organizing the Duchenne Patient Academy with WDO. Focused on data infrastructure for DMD research, making it a tightly coupled peer in research and advocacy.
- TREAT-NMD Alliance: Global neuromuscular disease research network. WDO participates in Euro-NMD Registry Hub with TREAT-NMD-affiliated institutions, working on the same patient registry and trial-readiness infrastructure.
Broad incumbents
- Muscular Dystrophy Association (MDA): Large US-based nonprofit covering multiple neuromuscular diseases including DMD. MDA operates a broader portfolio but is frequently cited alongside WDO in DMD/BMD advocacy and research contexts.
- AFM-Téléthon: Major French neuromuscular disease organization and research funder. Comparable scale and mission in funding neuromuscular research and supporting affected families across multiple conditions.
- National Organization for Rare Disorders (NORD): Premier US rare disease umbrella organization. Comparable role in the US rare disease ecosystem that EURORDIS plays in Europe, with overlapping policy advocacy and patient empowerment programs.
- European Patients Forum (EPF): EU-level cross-disease patient advocacy umbrella. WDO supplies EPF's Toolkit on Patient Empowerment and participates in EPF Summer Training, positioning it as a peer in pan-European patient empowerment work.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
World Duchenne Organization social profiles
Digital presenceWorld Duchenne Organization financial estimates
Financial estimateRevenue estimate
Valuation estimate
World Duchenne Organization leadership team
Management profileNumber of profiles
Profiles2 records
World Duchenne Organization funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
World Duchenne Organization M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about World Duchenne Organization
What does World Duchenne Organization do?
World Duchenne Organization is a Dutch nonprofit patient advocacy foundation that serves as a global hub for the Duchenne and Becker muscular dystrophy (DMD/BMD) community. It offers an annual international Duchenne Care Conference, the Duchenne Patient Academy online advocate training program, the annual World Duchenne Awareness Day campaign, and contributes to EU-funded research initiatives (BIND, BEAMER, ERDERA, EURO-NMD Registry Hub, Trials@Home). Its core product is a comprehensive information and community platform delivered through its website, supporting families, caregivers, clinicians, and patient organizations with condition information, care standards, and clinical trial guidance.
Is World Duchenne Organization a public or private company?
World Duchenne Organization is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was World Duchenne Organization founded?
World Duchenne Organization was founded in 2005. It employs 11 to 50 people.
Where is World Duchenne Organization based?
World Duchenne Organization is headquartered in Veenendaal, Netherlands, in the Europe region.
How does World Duchenne Organization make money?
One revenue line is on record: donations and Grants.
Who are World Duchenne Organization's main competitors?
Direct peers on record are Duchenne UK, EURORDIS - Rare Diseases Europe, Rare Diseases International, Parent Project Muscular Dystrophy (PPMD), Duchenne Data Foundation and TREAT-NMD Alliance. Broad incumbents are Muscular Dystrophy Association (MDA), AFM-Téléthon, National Organization for Rare Disorders (NORD) and European Patients Forum (EPF).
Does World Duchenne Organization have an API?
No public API is recorded for World Duchenne Organization.
What industry is World Duchenne Organization in?
World Duchenne Organization's product category is Patient Advocacy and Rare Disease Support Services. Its primary akta.pro industry code is BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS), with a secondary code of HLAJAKAN, Global Health Research, Evidence & Technical Assistance Organizations. Its NAICS code is 624190 and its SIC code is 8600.